Evolus, Inc.EOLSNASDAQ
LOADING
|||
Switch Symbol:

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating
Buy
13 analysts·Moderate coverage
85%
Rating Distribution
Strong Buy
00%
Buy
1185%
Hold
215%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 247% higher.

Bear Case
$13.00
+177%
Consensus
$16.33
+247%
Bull Case
$19.00
+304%
Price Range13 analysts
Low
Consensus
High
$13.00
$19.00
Current Target
Current Price
$4.70
Upside to Target
$11.63

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 22, 2026BTIG
Evolus price target lowered to $13 from $18 at BTIG
Target:$13.00
+165.3%from $4.90
Jan 13, 2026Stifel Nicolaus
Evolus price target lowered to $17 from $20 at Stifel
Target:$17.00
+194.6%from $5.77
Dec 1, 2025Mizuho Securities
Evolus (EOLS) PT Lowered to $19 at Mizuho
Target:$19.00
+178.6%from $6.82
Oct 3, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS)
Target:$27.00
+58.4%from $17.05
Sep 13, 2024Barclays
Evolus price target raised to $20 from $16 at Barclays
Target:$20.00
+21.5%from $16.46
Sep 13, 2024Mizuho Securities
Evolus (EOLS) PT Raised to $25 at Mizuho
Target:$25.00
+51.9%from $16.46
Jan 29, 2024Barclays
Barclays Upgrades Evolus (EOLS) to Overweight
Target:$16.00
+18.8%from $13.47